Skip to main content
Login
Contact
Subscribe
Search form
Search
The Kane Republican
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
KADC
Kane Area High School
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Bristol-Myers Squibb
(NY:
BMY
)
67.00
USD
+0.22 (+0.33%)
Streaming Delayed Price
/ Updated:
11:17 AM EST, Jan 17, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
3,394,917
Open
66.75
Bid (Size)
66.99 (6)
Ask (Size)
67.00 (9)
Prev. Close
66.78
Today's Range
66.72 - 67.17
52wk Range
42.48 - 67.09
Shares Outstanding
1,634,538,458
Dividend Yield
2.39%
Performance
YTD
+5.78%
+5.78%
1 Month
+4.51%
+4.51%
3 Month
+27.81%
+27.81%
6 Month
+52.10%
+52.10%
1 Year
+36.37%
+36.37%
Top News
More News
New Study Indicates 'Helper' Cells May Kill Cancerous Tumors
January 16, 2020
FN Media Group Presents USA News Group Market Commentary
Read More
from
PR Newswire
New Study Indicates ‘Helper’ Cells May Kill Cancerous Tumors
January 16, 2020
category
Featured News
from
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
More News
Read More
U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) in First-Line Non-Small Cell Lung Cancer
January 15, 2020
from
Business Wire News Releases
Castle Could Crumble When IPO Lockup Expires
Today 9:40 EST
category
Stocks / Equities
,
Healthcare
from
Blogs - TalkMarkets
Nektar Therapeutics and Bristol-Myers Squibb Amend Strategic Collaboration Agreement for bempegaldesleukin Plus Opdivo (nivolumab)
January 10, 2020
from
Business Wire News Releases
FDA Advisory Committee Slams Nektar's New Opioid Drug
January 15, 2020
category
BMY
,
Market News
,
NKTR
from
Motley Fool
Bristol-Myer Sqb Shares Up 45.2% Since SmarTrend's Buy Recommendation (BMY)
January 14, 2020
from
Comtex SmarTrend® News Briefs
Why Nektar Therapeutics Stock Is Sinking Today
January 15, 2020
category
Market News
,
BMY
,
NKTR
from
Motley Fool
Barron's Picks And Pans: Apple, Bank of America, Lockheed Martin And More
January 11, 2020
category
INTC
,
WFC
,
Market News
, and 13 more.
from
Benzinga
2020 J.P. Morgan Healthcare Conference Roundup
January 13, 2020
category
BMY
,
Market News
,
ABBV
, and 2 more.
from
Motley Fool
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
January 10, 2020
category
IBB
,
Analyst Ratings
,
Health Care
, and 19 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
